Published in Curr Top Med Chem on January 01, 2013
Functional architecture of MFS D-glucose transporters. Proc Natl Acad Sci U S A (2014) 1.04
SLC transporters as therapeutic targets: emerging opportunities. Nat Rev Drug Discov (2015) 1.02
How drugs get into cells: tested and testable predictions to help discriminate between transporter-mediated uptake and lipoidal bilayer diffusion. Front Pharmacol (2014) 1.00
Ligand Discovery for the Alanine-Serine-Cysteine Transporter (ASCT2, SLC1A5) from Homology Modeling and Virtual Screening. PLoS Comput Biol (2015) 0.83
Exercise training causes differential changes in gene expression in diaphragm arteries and 2A arterioles of obese rats. J Appl Physiol (1985) (2015) 0.82
Exercise-induced differential changes in gene expression among arterioles of skeletal muscles of obese rats. J Appl Physiol (1985) (2015) 0.82
Structure-Based Identification of Inhibitors for the SLC13 Family of Na(+)/Dicarboxylate Cotransporters. Biochemistry (2015) 0.81
Determinants of substrate and cation transport in the human Na+/dicarboxylate cotransporter NaDC3. J Biol Chem (2014) 0.81
SLC Transporters: Structure, Function, and Drug Discovery. Medchemcomm (2016) 0.79
Enrichment of chemical libraries docked to protein conformational ensembles and application to aldehyde dehydrogenase 2. J Chem Inf Model (2014) 0.77
Computational modeling to predict the functions and impact of drug transporters. In Silico Pharmacol (2015) 0.77
LAT-1 activity of meta-substituted phenylalanine and tyrosine analogs. Bioorg Med Chem Lett (2016) 0.76
Putative transmembrane transporter modulates higher-level aggression in Drosophila. Proc Natl Acad Sci U S A (2017) 0.75
Identification of nuclear genes controlling chlorophyll synthesis in barley by RNA-seq. BMC Plant Biol (2016) 0.75
Bypassing P-Glycoprotein Drug Efflux Mechanisms: Possible Applications in Pharmacoresistant Schizophrenia Therapy. Biomed Res Int (2015) 0.75
LAT1 activity of carboxylic acid bioisosteres: Evaluation of hydroxamic acids as substrates. Bioorg Med Chem Lett (2016) 0.75
ρ⁰ Cells Feature De-Ubiquitination of SLC Transporters and Increased Levels and Fluxes of Amino Acids. Int J Mol Sci (2017) 0.75
Solute carriers affect Anopheles stephensi survival and Plasmodium berghei infection in the salivary glands. Sci Rep (2017) 0.75
UCSF Chimera--a visualization system for exploratory research and analysis. J Comput Chem (2004) 112.47
Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res (2003) 103.76
Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol (1993) 64.61
The HHpred interactive server for protein homology detection and structure prediction. Nucleic Acids Res (2005) 21.68
Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct (2000) 17.81
ZINC--a free database of commercially available compounds for virtual screening. J Chem Inf Model (2005) 16.75
DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res (2006) 15.19
Crystal structure of a bacterial homologue of Na+/Cl--dependent neurotransmitter transporters. Nature (2005) 12.56
Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol (2006) 11.56
Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell (2008) 11.18
Structure and mechanism of the lactose permease of Escherichia coli. Science (2003) 10.57
Membrane transporters in drug development. Nat Rev Drug Discov (2010) 8.56
Bidirectional transport of amino acids regulates mTOR and autophagy. Cell (2009) 7.88
Simple allosteric model for membrane pumps. Nature (1966) 7.78
PROMALS3D: a tool for multiple protein sequence and structure alignments. Nucleic Acids Res (2008) 7.16
OPM: orientations of proteins in membranes database. Bioinformatics (2006) 5.87
Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc Natl Acad Sci U S A (2003) 5.77
A functional-phylogenetic classification system for transmembrane solute transporters. Microbiol Mol Biol Rev (2000) 5.65
Benchmarking sets for molecular docking. J Med Chem (2006) 5.57
A competitive inhibitor traps LeuT in an open-to-out conformation. Science (2008) 4.86
Virtual screening of chemical libraries. Nature (2004) 4.84
Transmembrane protein topology prediction using support vector machines. BMC Bioinformatics (2009) 4.67
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J Clin Invest (2007) 4.47
The mechanism of a neurotransmitter:sodium symporter--inward release of Na+ and substrate is triggered by substrate in a second binding site. Mol Cell (2008) 4.29
Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside. Nature (2003) 4.27
The Transporter Classification Database: recent advances. Nucleic Acids Res (2008) 4.26
Coupling substrate and ion binding to extracellular gate of a sodium-dependent aspartate transporter. Nature (2007) 4.14
The HUGO Gene Nomenclature Committee (HGNC). Hum Genet (2001) 3.89
The ABCs of solute carriers: physiological, pathological and therapeutic implications of human membrane transport proteinsIntroduction. Pflugers Arch (2003) 3.76
Structure-based strategies for drug design and discovery. Science (1992) 3.72
Lessons from lactose permease. Annu Rev Biophys Biomol Struct (2006) 3.69
Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature (1991) 3.46
Expression cloning and characterization of a transporter for large neutral amino acids activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem (1998) 3.44
Structure and molecular mechanism of a nucleobase-cation-symport-1 family transporter. Science (2008) 3.39
Structure and mechanism of a Na+-independent amino acid transporter. Science (2009) 3.30
Molecular basis of transport and regulation in the Na(+)/betaine symporter BetP. Nature (2009) 3.27
Mechanism for alternating access in neurotransmitter transporters. Proc Natl Acad Sci U S A (2008) 3.24
X-ray structures of LeuT in substrate-free outward-open and apo inward-open states. Nature (2012) 3.24
A comprehensive structure-based alignment of prokaryotic and eukaryotic neurotransmitter/Na+ symporters (NSS) aids in the use of the LeuT structure to probe NSS structure and function. Mol Pharmacol (2006) 3.23
Unlocking the molecular secrets of sodium-coupled transporters. Nature (2009) 3.23
Using sequence similarity networks for visualization of relationships across diverse protein superfamilies. PLoS One (2009) 3.03
Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics. Clin Pharmacol Ther (2007) 2.80
The binding sites for cocaine and dopamine in the dopamine transporter overlap. Nat Neurosci (2008) 2.72
CATs and HATs: the SLC7 family of amino acid transporters. Pflugers Arch (2003) 2.69
Crystal structure of a bacterial homologue of glucose transporters GLUT1-4. Nature (2012) 2.64
Lead discovery using molecular docking. Curr Opin Chem Biol (2002) 2.62
Comparative modeling for protein structure prediction. Curr Opin Struct Biol (2006) 2.60
The structural basis of secondary active transport mechanisms. Biochim Biophys Acta (2010) 2.56
Structure of a prokaryotic virtual proton pump at 3.2 A resolution. Nature (2009) 2.53
Molecular basis of alternating access membrane transport by the sodium-hydantoin transporter Mhp1. Science (2010) 2.52
Synaptic uptake and beyond: the sodium- and chloride-dependent neurotransmitter transporter family SLC6. Pflugers Arch (2003) 2.45
The rocking bundle: a mechanism for ion-coupled solute flux by symmetrical transporters. Physiology (Bethesda) (2009) 2.41
Single-molecule dynamics of gating in a neurotransmitter transporter homologue. Nature (2010) 2.41
Structure and mechanism of an amino acid antiporter. Science (2009) 2.40
A human transporter protein that mediates the final excretion step for toxic organic cations. Proc Natl Acad Sci U S A (2005) 2.34
Prediction and assignment of function for a divergent N-succinyl amino acid racemase. Nat Chem Biol (2007) 2.29
Membrane protein structure: prediction versus reality. Annu Rev Biochem (2007) 2.21
Ion/substrate-dependent conformational dynamics of a bacterial homolog of neurotransmitter:sodium symporters. Nat Struct Mol Biol (2010) 2.20
Substrate-modulated gating dynamics in a Na+-coupled neurotransmitter transporter homologue. Nature (2011) 2.18
Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment. Structure (2011) 2.11
Ligand discovery from a dopamine D3 receptor homology model and crystal structure. Nat Chem Biol (2011) 2.10
Structure and function of Na(+)-symporters with inverted repeats. Curr Opin Struct Biol (2009) 2.10
Protein structure prediction: inroads to biology. Mol Cell (2005) 2.08
Outcome of a workshop on applications of protein models in biomedical research. Structure (2009) 2.05
Crystal structure of a prokaryotic homologue of the mammalian oligopeptide-proton symporters, PepT1 and PepT2. EMBO J (2010) 2.05
Nuclear hormone receptor targeted virtual screening. J Med Chem (2003) 2.05
Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1. Proc Natl Acad Sci U S A (2003) 2.03
Automatic prediction of protein function. Cell Mol Life Sci (2003) 2.03
Common variants in 40 genes assessed for diabetes incidence and response to metformin and lifestyle intervention in the diabetes prevention program. Diabetes (2010) 2.02
Neurotransmitter transporters: molecular function of important drug targets. Trends Pharmacol Sci (2006) 2.01
All are not equal: a benchmark of different homology modeling programs. Protein Sci (2005) 1.99
A composite score for predicting errors in protein structure models. Protein Sci (2006) 1.92
Mechanism of substrate recognition and transport by an amino acid antiporter. Nature (2010) 1.92
Discovery of a dipeptide epimerase enzymatic function guided by homology modeling and virtual screening. Structure (2008) 1.91
The alternating-access mechanism of MFS transporters arises from inverted-topology repeats. J Mol Biol (2011) 1.83
Identification and functional characterization of a new human kidney-specific H+/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2. J Am Soc Nephrol (2006) 1.80
Organic cation transporters. Rev Physiol Biochem Pharmacol (2003) 1.77
Structure of a cation-bound multidrug and toxic compound extrusion transporter. Nature (2010) 1.72
Crystal structure of a bacterial homologue of the bile acid sodium symporter ASBT. Nature (2011) 1.72
Structure-based drug screening for G-protein-coupled receptors. Trends Pharmacol Sci (2012) 1.72
Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy. Handb Exp Pharmacol (2011) 1.69
Rapid context-dependent ligand desolvation in molecular docking. J Chem Inf Model (2010) 1.66
Structure-based discovery of inhibitors of thymidylate synthase. Science (1993) 1.61
Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus. Pharmacogenomics J (2009) 1.58
Sodium-coupled neurotransmitter transporters. Chem Rev (2008) 1.58
Using multiple templates to improve quality of homology models in automated homology modeling. Protein Sci (2008) 1.56
How well can the accuracy of comparative protein structure models be predicted? Protein Sci (2008) 1.52
Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening. J Med Chem (2008) 1.52
Binding of serotonin to the human serotonin transporter. Molecular modeling and experimental validation. J Am Chem Soc (2008) 1.50
Assessment of ligand-binding residue predictions in CASP9. Proteins (2011) 1.47
Prognostic significance of L-type amino acid transporter 1 expression in resectable stage I-III nonsmall cell lung cancer. Br J Cancer (2008) 1.46
Structure and mechanism of a glutamate-GABA antiporter. Nature (2012) 1.46
Alignment of multiple protein structures based on sequence and structure features. Protein Eng Des Sel (2009) 1.43
Function of human Rh based on structure of RhCG at 2.1 A. Proc Natl Acad Sci U S A (2010) 1.41
Structural basis of Na(+)-independent and cooperative substrate/product antiport in CaiT. Nature (2010) 1.36
Molecular docking screens using comparative models of proteins. J Chem Inf Model (2009) 1.36
The solute carrier (SLC) complement of the human genome: phylogenetic classification reveals four major families. FEBS Lett (2008) 1.34
Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. J Med Chem (2011) 1.30
Comparison of human solute carriers. Protein Sci (2010) 1.29
Structure and mechanism of the uracil transporter UraA. Nature (2011) 1.29
Statistical potential for assessment and prediction of protein structures. Protein Sci (2006) 8.98
Membrane transporters in drug development. Nat Rev Drug Discov (2010) 8.56
Modeller: generation and refinement of homology-based protein structure models. Methods Enzymol (2003) 7.15
The molecular architecture of the nuclear pore complex. Nature (2007) 6.93
Protein structure modeling with MODELLER. Methods Mol Biol (2008) 6.28
Comparative protein structure modeling using MODELLER. Curr Protoc Protein Sci (2007) 5.81
Natural variation in human membrane transporter genes reveals evolutionary and functional constraints. Proc Natl Acad Sci U S A (2003) 5.77
Determining the architectures of macromolecular assemblies. Nature (2007) 4.94
MODBASE, a database of annotated comparative protein structure models, and associated resources. Nucleic Acids Res (2004) 4.54
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action. J Clin Invest (2007) 4.47
Outcome of the first electron microscopy validation task force meeting. Structure (2012) 4.35
Global sequencing of proteolytic cleavage sites in apoptosis by specific labeling of protein N termini. Cell (2008) 4.00
Protein production and purification. Nat Methods (2008) 3.97
FoXS: a web server for rapid computation and fitting of SAXS profiles. Nucleic Acids Res (2010) 3.91
Global landscape of HIV-human protein complexes. Nature (2011) 3.70
Tools for comparative protein structure modeling and analysis. Nucleic Acids Res (2003) 3.68
MODBASE: a database of annotated comparative protein structure models and associated resources. Nucleic Acids Res (2006) 3.56
Molecular architecture of the 26S proteasome holocomplex determined by an integrative approach. Proc Natl Acad Sci U S A (2012) 3.42
ModLoop: automated modeling of loops in protein structures. Bioinformatics (2003) 3.31
The molecular sociology of the cell. Nature (2007) 3.23
Protein structure fitting and refinement guided by cryo-EM density. Structure (2008) 3.12
LS-SNP: large-scale annotation of coding non-synonymous SNPs based on multiple information sources. Bioinformatics (2005) 3.05
Study of the structural dynamics of the E coli 70S ribosome using real-space refinement. Cell (2003) 3.03
Multiple conformations of E. coli Hsp90 in solution: insights into the conformational dynamics of Hsp90. Structure (2008) 2.98
ModBase, a database of annotated comparative protein structure models, and associated resources. Nucleic Acids Res (2010) 2.96
Statistical potentials for fold assessment. Protein Sci (2002) 2.92
Components of coated vesicles and nuclear pore complexes share a common molecular architecture. PLoS Biol (2004) 2.90
Alignment of protein sequences by their profiles. Protein Sci (2004) 2.80
Vif hijacks CBF-β to degrade APOBEC3G and promote HIV-1 infection. Nature (2011) 2.71
Genomic-scale prioritization of drug targets: the TDR Targets database. Nat Rev Drug Discov (2008) 2.58
Rare versus common variants in pharmacogenetics: SLCO1B1 variation and methotrexate disposition. Genome Res (2011) 2.52
EVA: Evaluation of protein structure prediction servers. Nucleic Acids Res (2003) 2.50
Comparative protein structure modeling by iterative alignment, model building and model assessment. Nucleic Acids Res (2003) 2.44
PIBASE: a comprehensive database of structurally defined protein interfaces. Bioinformatics (2005) 2.39
Reliability of assessment of protein structure prediction methods. Structure (2002) 2.39
Organic cation transporters are determinants of oxaliplatin cytotoxicity. Cancer Res (2006) 2.37
Putting the pieces together: integrative modeling platform software for structure determination of macromolecular assemblies. PLoS Biol (2012) 2.37
Simple fold composition and modular architecture of the nuclear pore complex. Proc Natl Acad Sci U S A (2006) 2.35
Integrating diverse data for structure determination of macromolecular assemblies. Annu Rev Biochem (2008) 2.35
A conserved coatomer-related complex containing Sec13 and Seh1 dynamically associates with the vacuole in Saccharomyces cerevisiae. Mol Cell Proteomics (2011) 2.34
Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges. Nat Rev Drug Discov (2007) 2.32
Outcome of a workshop on archiving structural models of biological macromolecules. Structure (2006) 2.32
Germline genetic variation in an organic anion transporter polypeptide associated with methotrexate pharmacokinetics and clinical effects. J Clin Oncol (2009) 2.20
Comparative Protein Structure Modeling Using MODELLER. Curr Protoc Bioinformatics (2014) 2.17
The C-type lectin fold as an evolutionary solution for massive sequence variation. Nat Struct Mol Biol (2005) 2.13
Structure of the mammalian 80S ribosome at 8.7 A resolution. Structure (2008) 2.11
Ligand discovery from a dopamine D3 receptor homology model and crystal structure. Nat Chem Biol (2011) 2.10
UCSF Chimera, MODELLER, and IMP: an integrated modeling system. J Struct Biol (2011) 2.10
The concentrative nucleoside transporter family, SLC28. Pflugers Arch (2003) 2.06
Refinement of protein structures by iterative comparative modeling and CryoEM density fitting. J Mol Biol (2006) 2.06
Outcome of a workshop on applications of protein models in biomedical research. Structure (2009) 2.05
Integration of small-angle X-ray scattering data into structural modeling of proteins and their assemblies. J Mol Biol (2008) 2.05
Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1. Proc Natl Acad Sci U S A (2003) 2.03
Global identification and characterization of both O-GlcNAcylation and phosphorylation at the murine synapse. Mol Cell Proteomics (2012) 2.03
MODBASE, a database of annotated comparative protein structure models and associated resources. Nucleic Acids Res (2008) 2.02
MODBASE, a database of annotated comparative protein structure models. Nucleic Acids Res (2002) 2.01
ModView, visualization of multiple protein sequences and structures. Bioinformatics (2003) 1.99
A structural perspective on protein-protein interactions. Curr Opin Struct Biol (2004) 1.98
Population level functional diversity in a microbial community revealed by comparative genomic and metagenomic analyses. ISME J (2007) 1.97
Pharmacogenomics: challenges and opportunities. Ann Intern Med (2006) 1.96
A composite score for predicting errors in protein structure models. Protein Sci (2006) 1.92
Structural genomics: a pipeline for providing structures for the biologist. Protein Sci (2002) 1.91
Determination of cancer risk associated with germ line BRCA1 missense variants by functional analysis. Cancer Res (2007) 1.89
The Enzyme Function Initiative. Biochemistry (2011) 1.87
Structure-based assessment of missense mutations in human BRCA1: implications for breast and ovarian cancer predisposition. Cancer Res (2004) 1.84
Accurate SAXS profile computation and its assessment by contrast variation experiments. Biophys J (2013) 1.83
Insights into the molecular architecture of the 26S proteasome. Proc Natl Acad Sci U S A (2009) 1.81
Sequence diversity and haplotype structure in the human ABCB1 (MDR1, multidrug resistance transporter) gene. Pharmacogenetics (2003) 1.79
Evidence for a shared nuclear pore complex architecture that is conserved from the last common eukaryotic ancestor. Mol Cell Proteomics (2009) 1.74
Subnanometer-resolution electron cryomicroscopy-based domain models for the cytoplasmic region of skeletal muscle RyR channel. Proc Natl Acad Sci U S A (2008) 1.68
Structural characterization of components of protein assemblies by comparative modeling and electron cryo-microscopy. J Struct Biol (2005) 1.67
Protein structure modeling with MODELLER. Methods Mol Biol (2014) 1.65
cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: Uptake, structure, function, and prospects. Proc Natl Acad Sci U S A (2008) 1.62
LigBase: a database of families of aligned ligand binding sites in known protein sequences and structures. Bioinformatics (2002) 1.62
Crystal structure of a eukaryotic phosphate transporter. Nature (2013) 1.60
Gene expression profiling of the human maternal-fetal interface reveals dramatic changes between midgestation and term. Endocrinology (2006) 1.58
The proteasomal subunit Rpn6 is a molecular clamp holding the core and regulatory subcomplexes together. Proc Natl Acad Sci U S A (2011) 1.57
Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function. Pharmacogenetics (2002) 1.57
High-throughput computational and experimental techniques in structural genomics. Genome Res (2004) 1.55
Biochemistry. Integrative structural biology. Science (2013) 1.52
How well can the accuracy of comparative protein structure models be predicted? Protein Sci (2008) 1.52
Mechanism of lid closure in the eukaryotic chaperonin TRiC/CCT. Nat Struct Mol Biol (2008) 1.51
Functional impact of missense variants in BRCA1 predicted by supervised learning. PLoS Comput Biol (2006) 1.49
Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin. Pharmacogenet Genomics (2010) 1.48
Inferential optimization for simultaneous fitting of multiple components into a CryoEM map of their assembly. J Mol Biol (2009) 1.48
Transport of drugs in the kidney by the human organic cation transporter, OCT2 and its genetic variants. J Pharm Sci (2006) 1.48
Genetics of P450 oxidoreductase: sequence variation in 842 individuals of four ethnicities and activities of 15 missense mutations. Proc Natl Acad Sci U S A (2008) 1.47
Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin. Pharmacogenet Genomics (2009) 1.46
Structure-function mapping of a heptameric module in the nuclear pore complex. J Cell Biol (2012) 1.44
Lack of support for a role for RLIP76 (RALBP1) in response to treatment or predisposition to epilepsy. Epilepsia (2007) 1.43
Alignment of multiple protein structures based on sequence and structure features. Protein Eng Des Sel (2009) 1.43
Finding cures for tropical diseases: is open source an answer? PLoS Med (2004) 1.41
Function of human Rh based on structure of RhCG at 2.1 A. Proc Natl Acad Sci U S A (2010) 1.41
Structural genomics of protein phosphatases. J Struct Funct Genomics (2007) 1.40
Report of the wwPDB Small-Angle Scattering Task Force: data requirements for biomolecular modeling and the PDB. Structure (2013) 1.39
Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variants. J Pharmacol Exp Ther (2006) 1.38
Metformin pathways: pharmacokinetics and pharmacodynamics. Pharmacogenet Genomics (2012) 1.38
Molecular docking screens using comparative models of proteins. J Chem Inf Model (2009) 1.36
Interactions of tyrosine kinase inhibitors with organic cation transporters and multidrug and toxic compound extrusion proteins. Mol Cancer Ther (2011) 1.35